{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:59:46Z","timestamp":1759564786978,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jhep.2020.11.041","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T19:59:31Z","timestamp":1606766371000},"page":"750-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ulipristal acetate and liver-injuries: while Esmya is revoked, EllaOne is allowed in repeated self-administrations possibly exceeding UPA toxic-dosing with Esmya"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8649-0693","authenticated-orcid":false,"given":"Bruno","family":"Mozzanega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.11.041_bib4","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.clinre.2020.02.008","article-title":"Case report. Acute liver failure requiring transplantation caused by ulipristal acetate","volume":"44","author":"Meunier","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.041_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jcpt.12065","article-title":"Ulipristal acetate \u2013 safety and pharmacokinetics following multiple doses of 10\u201350 mg per day","volume":"38","author":"Pohl","year":"2013","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"12","key":"10.1016\/j.jhep.2020.11.041_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s40264-020-00975-8","article-title":"Liver injury with ulipristal acetate: exploring the underlying pharmacological basis","volume":"43","author":"Gatti","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2020.11.041_bib9","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3389\/fphar.2019.01235","article-title":"Strategies for early prediction and timely recognition of drug-induced liver injury: the case of cyclin- dependent kinase 4\/6 inhibitors","volume":"10","author":"Raschi","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.041_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625187.2018.1555662","article-title":"UPA and LNG in emergency contraception: the information by EMA and the scientific evidences indicate a prevalent anti-implantation effect","volume":"24","author":"Mozzanega","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:42:49Z","timestamp":1759174969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820338289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0168827820338289"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.041","relation":{},"ISSN":["0168-8278"],"issn-type":[{"type":"print","value":"0168-8278"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulipristal acetate and liver-injuries: while Esmya is revoked, EllaOne is allowed in repeated self-administrations possibly exceeding UPA toxic-dosing with Esmya","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}